Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Single-center, Randomized, Double-Blinded, Parallel-group, Active Controlled Study to Evaluate the Efficacy and Safety of a Single Dose of Emodepside Compared to Multiple Doses of Mebendazole in Adolescent and Adult Participants With Soil-transmitted Helminthiasis

NCT06800248 is registered in ClinicalTrials.gov with Swiss Tropical & Public Health Institute as lead sponsor.

NCT NCT06800248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06800248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Single-center, Randomized, Double-Blinded, Parallel-group, Active Controlled Study to Evaluate the Efficacy and Safety of a Single Dose of Emodepside Compared to Multiple Doses of Mebendazole in Adolescent and Adult Participants With Soil-transmitted Helminthiasis
Lead sponsor
Swiss Tropical & Public Health Institute
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 6, 2026
Completion date
October 31, 2027
Enrollment
315 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascaris lumbricoides infection, hookworm infection, trichuris trichiura; infection